If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

Men diagnosed at screening aged 50 years projected to have 16 percent chance that cancer would not have been detected within 15 years.

Prostate cancer is a significant health issue that affects many men worldwide. Despite its prevalence, conversations about prostate cancer between fathers and sons are often overlooked or avoided.

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

Former President Joe Biden was diagnosed last week with an aggressive form of prostate cancer that has spread to his bones. The news has raised lots of questions about the typically slow-growing ...

Medicare covers screenings and treatment for prostate cancer, with Part A covering hospital care and Part B covering outpatient care and outpatient cancer medications. Original Medicare (parts A and B ...